Drugs / 3% hypertonic saline
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT02029040 | Dec 2013 → Dec 2014 | acute bronchiolitis | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| — | NCT01120496 | Nov 2008 → Nov 2009 | bronchiolitis | Chongqing Medical University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02887469 Comparator | Aug 2016 → Sep 2019 | — | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3% hypertonic saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02887469 ↗ |
| Route | Inhaled | “frequently inhaled hypertonic saline (HS)” NCT01120496 ↗ |